USP is engaging with internal and external stakeholders to define compendial standards of the future. Our work in this area involves identifying new standards in emerging pharmaceutical development, establishing use and application of new standards, and managing the life cycle of these new standards.
To this end, we are exploring these and other areas such as:
- Pharmaceutical Continuous Manufacturing (PCM)
- Standardization of Digital Health
- Quality by Design
- Personalized Medicine
- 3D Printing